SCHEMBL7962791

SCHEMBL7962791

CCCOc1ccc(CN2CCN(C)CC2)cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 19/20 0.64
PDE6C P51160 2/20 0.64
PDE3B Q13370 2/20 0.64
PDE3A Q14432 2/20 0.64
PDE1A P54750 2/20 0.64
PDE1B Q01064 2/20 0.64
PDE1C Q14123 2/20 0.64
PDE2A O00408 1/20 0.64
ABCC4 O15439 1/20 0.64
ABCC5 O15440 1/20 0.64
PDE6D O43924 1/20 0.64
PDE8A O60658 1/20 0.64
PDE9A O76083 1/20 0.64
ABCB11 O95342 1/20 0.64
CYP3A4 P08684 1/20 0.64
HTR1A P08908 1/20 0.64
PDE6A P16499 1/20 0.64
PDE6G P18545 1/20 0.64
PDE4A P27815 1/20 0.64
ADORA2A P29274 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL681658 0.94 PDE5A (0.71) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL7962137 0.92 PDE5A (0.67) PDE5APDE6CHDAC6HDAC1HDAC2
SCHEMBL15423769 0.91 PDE5A (0.68) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL17390180 0.88 PDE5A (0.72) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL8281603 0.87 PDE5A (0.55) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL7960910 0.86 PDE5A (0.64) PDE5APDE6CPDE3APDE1APDE1B
SCHEMBL7965467 0.86 PDE5A (0.66) PDE5APDE6CPDE3APDE1APDE1B
SCHEMBL7959160 0.85 PDE5A (0.77) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL7962710 0.84 PDE5A (0.64) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL28417921 0.84 PDE5A (0.89) PDE5APDE6CPDE3BPDE3APDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6200980-B1 ADMINISTERING PHENYL PURINONE COMPOUND FOR TREATING PRECANCEROUS LEISONS CELL PATHWAYS, INC. 2001-03-13 US disclosed
EP-0526004-B1 Pyrazolopyrimidinone antianginal agents PFIZER LTD (GB) 1997-10-08 EP disclosed
US-5426107-A Treatment of cardiovascular disorders, asthma, allergies PFIZER INC. (US) 1995-06-20 US disclosed
US-5272147-A Pyrazolopyrimidinone antianginal agents PFIZER INC. (US) 1993-12-21 US disclosed
EP-0526004-A1 Pyrazolopyrimidinone antianginal agents Pfizer Limited (GB) 1993-02-03 EP disclosed